Document is current
Any future updates will be listed below
-
Authors
Imanaka, Ryota
Numata, Hiroki
Katsuoka, Yuna
Uoshima, Nobuhiko
Hara, Satoru
Ando, Jun
Ota, Shuichi
Yoshimoto, Goichi
Matsuoka, Akihito
Morita, Tetsuo
Tsutsui, Atsuko
Kosugi-Kanaya, Mizuha
Goto, Tatsunori https://orcid.org/0000-0002-0314-9498
-
Funding
Funding for this research was provided by:
AbbVie GK
- License Information
-
More Information
Article History
Received: 15 June 2025
Revised: 21 October 2025
Accepted: 22 October 2025
First Online: 7 November 2025
Declarations
:
: Hiroki Numata has received grants from AbbVie. Nobuhiko Uoshima has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AbbVie, Bristol Myers Squibb, and Janssen. Jun Ando has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AbbVie. Shuichi Ota has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Novartis, Takeda, AstraZeneca, AbbVie, PharmaEssentia, Bristol Myers Squibb, Janssen, Amgen, and Sanofi. Goichi Yoshimoto has received honoraria from AbbVie. Tetsuo Morita, Atsuko Tsutsui, and Mizuha Kosugi-Kanaya are employees of AbbVie. Tetsuo Morita and Atsuko Tsutsui hold stock and/or stock options in AbbVie. Tatsunori Goto has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AbbVie and Nippon Shinyaku. The other authors declare no conflicts of interest.
